Abstract
Janowsky, Davis and colleagues began in 1972 to explore the possibility that the affective disorders, mania and depression, might be due to a complex balance, or inter-action, between adrenergic and cholinergic factors (Janowsky et al., 1972a). Proposed most simply, mania was hypothesized to be a syndrome due to relatively diminished central acetylcholine (ACh) activity, compared to normal or increased noradrenergic and/or dopaminergic activity; and depression was proposed to be the converse (Janowsky et al., 1972b).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beigel, A., and Murphy, D.L., 1971, Assessing clinical characteristics of the manic state, Am. J. Psychiatry 128: 688.
Bowers, M.B., Goodman, E., and Sim, V.M., 1964, Some behavioral changes in man following anticholinesterase administration, J. Nerv. Merit. Dis. 138: 383.
Brown, H., 1971, Some anticholinergic-like behavioral effects of trans (-) - Δ8-tetrahydro-cannabinol, Psychopharmacologia 21: 294.
Carroll, B.J., Frazer, A., Schless, A., and Mendels, A., 1973, Cholinergic reversal of manic symptoms, Lancet 7: 427.
Casey, D.E., and Denney, D., 1977, Pharmacological characterization of tardive dyskinesia, Psychopharmacology 54: 1.
Cutler, R.P., and Kurland, H.D., 1961, Clinical quantification of depressive reactions, Arch. Gen. Psychiatry 5: 88.
Davis, J.M., 1970, Theories of the biological etiology of affective disorders, Int. Rev. Neurobiol. 72: 145.
Davis, J.M., Janowsky, D.S., Tamminga, C., and Smith, R.C., 1976, Cholinergic Mechanisms and Psychopharmacology (D.J. Jenden, ed.), Plenum Publishing Corporation, New York.
Davis, K.L., Hollister, L.E., Overall, J., Johnson, A., and Train, K., 1976, Physostigmine: effects on cognition and affect in normal subjects, Psychopharmacology 51: 23.
Davis, K.L., Hollister, L.E., Goodwin, F.K., and Gordon, E.K., 1977, Neurotransmitter metabolites in the cerebrospinal fluid ofman following physostigmine, Life Sci. 21: 933.
Davis, K.L., Berger, P.A., Hollister, L.E., and Defraites, E., 1978, Physostigmine in mania, Arch. Gen. Psychiatry 35(1)J: 119.
El-Yousef, M.K., Janowsky, D.S., Davis, J.M., and Rosenblatt, J.R., 1973, Induction of severe depression by physostigmine in marijuana intoxicated individuals, Br. J. Addict. 68: 321.
Fibiger, J.D., Lynch, G.S., and Cooper, H.P., 1971, A biphasic action of central cholinergic stimulation on behavioral arousal in the rat, Psychopharmacologia 20: 366.
Gershon, S., and Shaw, F.H., 1961, Psychiatric sequelae of chronic exposure to organo-phosphorous insecticides, Lancet I: 1371.
Goodman, L.S., and Gilman, A., (eds.), 1970, “The Pharmacological Basis of Therapeutics, 4th Ed.,” Collier-MacMillan, Toronto, Canada.
Gorny, D., Billewicz-Stankiewicz, J., Zajqczkowska, M., and Kutarski, A., 1976, Effect of noradrenaline on the content, synthesis and catabolism of acetylcholine in the brain, Acta Physiol. Pol 27: 55.
Janowsky, D.S., El-Yousef, M.K., Davis, J.M., Sekerke, H.J., and Hubbard, B.J., 1972a, Cholinergic antagonism of manic symptoms, Lancet 7: 1236.
Janowsky, D.S., El-Yousef, M.K., Davis, J.M., and Sekerke, H.J., 1972b, A cholinergicadrenergic hypothesis of mania and depression, Lancet II: 632.
Janowsky, D.S., El-Yousef, M.K., Davis, J.M., Sekerke, H.J., 1972c, Cholinergic antagonism of methylphenidate-induced stereotyped behavior, Psychopharmacologia 27: 295.
Janowsky, D.S., El-Yousef, M.K., Davis, J.M., and Sekerke, H.J., 1973a, Parasympathetic suppression of manic symptoms by physostigmine, Arch. Gen. Psychiatry 28: 542.
Janowsky, D.S., Davis, J.M., El-Yousef, M.K., and Sekerke, H.J., 1973b, Acetylcholine and depression, Psychosom. Med. 35 (5): 56S.
Janowsky, D.S., El-Yousef, M.K., and Sekerke, H.J., 1973c, Antagonistic effects of physostigmine and methylphenidate in man, Am. J. Psychiatry 130: 1310.
Mandell, A.J., and Knapp, S., 1971, The effects of chronic administration of some cholinergic and adrenergic drugs on the activity of choline acetyltransferase in the optic lobe of the chick brain, Neuropharmacology 10: 513.
Meduna, L.J., and Abood, L.G., 1959, Studies of a new drug (DITRAN) in depressive states, J. Neuropsychiatry 1: 20.
Modestin, J.J., Hunger, R.B., and Schwartz, R.B., 1973a, Uber die depressogene Wirkung von Physostigmin, Arch. Psychiatr. Nervenkr. 218: 61.
Modestin, J.J., Schwartz, R.B., and Hunger, J., 1973b, Zur frage der beeinflussung schizo-phrener Symptome physostigmin, Pharmakopsychiatrie 9: 300.
Rosenblatt, J.E., Janowsky, D.S., Davis, J.M., and El-Yousef, M.K., 1972, The augmentation of physostigmine toxicity in the rat by Δ9-tetrahydrocannabinol, Res. Commun. Chem. Pathol. Pharmacol. 3(3): 419.
Rowntree, D.W., Neven, S., and Wilson, A., 1950, The effects of diisopropylfluorophos- phonate in schizophrenic and manic depressive psychosis, J. Neurol. Neurosurg. Psychiatry 13: 41.
Safer, D.J., and Allen, R.P., 1971, The central effects of scopolamine in man, Biol. Psychiatry 3: 341.
Schildkraut, J.J., 1965, The catecholamine hypothesis of affective disorders: a review of supporting evidence, Am. J. Psychiatry 122: 509.
Shopsin, B., Janowsky, D.S., Davis, J.M., and Gershon, S., 1975, Rebound phenomena in manic patients following physostigmine, Neuropsychobiology 7: 180.
Snyder, S.H., and Yamamura, H.I., 1977, Antidepressants and the muscarinic acetylcholine receptor, Arch. Gen. Psychiatry 34: 236.
Stadler, H., Lloyd, K.G., Gadea-Cira, M., and Bartholini, G., 1973, Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine, Brain Res. 55: 416.
Sulser, F., Bickel, M.H., and Brodie, B.B., 1964, The action of desmethylimipramine in counteracting sedation and cholinergic effects of reserpine-like drugs, J. Pharmacol. Exp. Ther. 144: 321.
Tamminga, C., Smith, R.C., Chang, S., Haraszti, J.S., and Davis, J.M., 1976, Depression associated with oral choline, Lancet II: 905.
Trabucchi, M., Cheney, D.L., Racagni, G., and Costa, E., 1975, In vivo inhibition of striatal acetylcholine turnover by L-DOPA, apomorphine and (+) -amphetamine, Brain Res. 85: 130.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Plenum Press, New York
About this chapter
Cite this chapter
Janowsky, D.S., Davis, J.M. (1979). Psychological Effects of Cholinomimetic Agents. In: Davis, K.L., Berger, P.A. (eds) Brain Acetylcholine and Neuropsychiatric Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2934-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2934-3_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-2936-7
Online ISBN: 978-1-4613-2934-3
eBook Packages: Springer Book Archive